Related Experiment Video

Updated: Apr 21, 2026

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

2.1K

N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes

Y Wang1, S R McAlpine

  • 1Department of chemistry, Gate 2 High street, Dalton 219, University of New South Wales, Sydney, NSW 2052, Australia. s.mcalpine@unsw.edu.au.

Chemical Communications (Cambridge, England)
|October 22, 2014
PubMed

Insights

Targeting heat shock protein 90 (Hsp90) at its C-terminus offers a novel cancer therapy. This approach avoids triggering the heat shock response (HSR), unlike traditional N-terminal inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Heat shock protein 90 (Hsp90) is crucial for cancer cell survival.
  • Conventional Hsp90 inhibitors target the N-terminus, inducing a protective heat shock response (HSR).
  • This HSR can limit the efficacy of traditional Hsp90-targeted cancer therapies.

Purpose of the Study:

  • To investigate an alternative strategy for inhibiting Hsp90.
  • To explore C-terminal modulation of Hsp90 as a therapeutic approach.
  • To determine if C-terminal inhibition bypasses the HSR.

Main Methods:

  • Developing novel compounds targeting the C-terminus of Hsp90.
  • Assessing the effects of these compounds on cancer cell viability.
  • Measuring the induction of the heat shock response (HSR) in response to C-terminal inhibition.

Main Results:

  • Inhibitors targeting the Hsp90 C-terminus effectively reduced cancer cell viability.
  • Crucially, C-terminal Hsp90 inhibition did not trigger the heat shock response (HSR).
  • This suggests a distinct mechanism of action compared to N-terminal inhibitors.

Conclusions:

  • Modulating the C-terminus of Hsp90 represents a promising chemotherapeutic strategy.
  • Bypassing the HSR could lead to more effective and durable cancer treatments.
  • Further research into C-terminal Hsp90 inhibitors is warranted for oncological applications.

More Related Videos

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans12:57

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans

Published on: January 8, 2015

15.7K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

7.7K

Related Concept Videos

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.3K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.5K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.0K